IntraPac is the leading provider and innovator of metereddose inhaler can
coating technology, a reputation we have held since introducing the process
to the global pharmaceutical market more than seven years ago. Specialized
flouropolymer coatings are applied and cured to the internal surface of the
inhaler cans to prevent the adherence of drug active on the can substrate.
The flouropolymer coating also provides a clean chemically inert contact layer
between the formulation and the aluminum substrate. This results in improved
dose reproducibility, shorter development programs, and superior formulations.
Our state-of-the-art lines are computer-regulated and monitored to ensure absolute precision and quality in the
manufacturing process. Stringent quality control requirements are also met by the facility’s pharmaceutical
standard clean room conditions.
IntraPac’s cans feature:
a range of coatings and can sizes that are compliant with regulatory authority requirements
coated can volumes from small test batch lots to large commercial batch sizes
a fully validated manufacturing program supported by our experienced technical support staff
a manufacturing facility that is supported by an up-todate Drug Master File
a production facility that operates with high standards of GMP
an ISO 9002 certified manufacturer (since November 1997)
IntraPac reserves the right to change or modify the design of its products without any obligation to provide notification of change or intent to change.
Inhaler Flouropolymer Coated Cans
IntraPac’s coated cans were developed
primarily for the asthma inhaler
market. Our products form part of a
superior delivery system. The cans
reduce adhesion of drug active to the
aerosol can wall and provide a clean
chemically inert surface.
IntraPac reserves the right to change or modify the design of its products without any obligation to provide notification of change or intent to change.
IntraPac is the leading provider and innovator of metereddose inhaler can
coating technology, a reputation we have held since introducing the process
to the global pharmaceutical market more than seven years ago. Specialized
flouropolymer coatings are applied and cured to the internal surface of the
inhaler cans to prevent the adherence of drug active on the can substrate.
The flouropolymer coating also provides a clean chemically inert contact layer
between the formulation and the aluminum substrate. This results in improved
dose reproducibility, shorter development programs, and superior formulations. 
